Functional assay measuring inhibition of factor Xa, used to monitor low-molecular-weight heparin (LMWH) and fondaparinux therapy. Target levels depend on agent, dose, and indication.
| Sex | Age | Range | Notes |
|---|---|---|---|
| All | ≥ 18 yrs | See notes | LMWH prophylaxis (4h post-dose): 0.2–0.4; treatment (4h peak): 0.5–1.0; trough <0.2 |
⚠ Clinical Note
Reference ranges are indicative. Always interpret results in the context of the individual patient and local laboratory reference intervals, which may vary.